Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Phase II Study of Subcutaneously Administered IFN-beta-1a in the Treatment of Patients With Moderately Active Ulcerative Colitis

NCT00303381 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT00303381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00303381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Phase II Study of Subcutaneously Administered IFN-beta-1a in the Treatment of Patients With Moderately Active Ulcerative Colitis
Lead sponsor
EMD Serono
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2001
Completion date
January 31, 2003
Enrollment
194 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis